Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T.

Lin K, Lloyd-Jones DM, Spottiswoode B, Bi X, Liu Y, Lu B, Xue H, Wang Y, Li D, Carr JC.

Invest Radiol. 2014 Apr;49(4):243-8. doi: 10.1097/RLI.0000000000000024.

PMID:
24473364
2.

Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.

Makowski MR, Wiethoff AJ, Uribe S, Parish V, Botnar RM, Bell A, Kiesewetter C, Beerbaum P, Jansen CH, Razavi R, Schaeffter T, Greil GF.

Radiology. 2011 Sep;260(3):680-8. doi: 10.1148/radiol.11102327. Epub 2011 May 25.

PMID:
21613441
3.

Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.

Frydrychowicz A, Russe MF, Bock J, Stalder AF, Bley TA, Harloff A, Markl M.

Acad Radiol. 2010 Nov;17(11):1394-400. doi: 10.1016/j.acra.2010.05.022. Epub 2010 Jul 22.

PMID:
20650665
4.

Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.

Doeblin P, Schilling R, Wagner M, Luhur R, Huppertz A, Hamm B, Taupitz M, Durmus T.

Eur J Radiol. 2014 Apr;83(4):660-4. doi: 10.1016/j.ejrad.2013.12.019. Epub 2013 Dec 27.

PMID:
24433640
5.
6.

T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 Apr 28;14:26. doi: 10.1186/1532-429X-14-26.

7.

First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.

Klessen C, Hein PA, Huppertz A, Voth M, Wagner M, Elgeti T, Kroll H, Hamm B, Taupitz M, Asbach P.

Invest Radiol. 2007 Sep;42(9):659-64.

PMID:
17700282
8.

Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.

Rudolph A, von Knobelsdorff-Brenkenhoff F, Wassmuth R, Prothmann M, Utz W, Schulz-Menger J.

J Magn Reson Imaging. 2014 May;39(5):1153-60. doi: 10.1002/jmri.24264. Epub 2013 Oct 22.

PMID:
24151119
9.

Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.

Schnorr J, Taupitz M, Schellenberger EA, Warmuth C, Fahlenkamp UL, Wagner S, Kaufels N, Wagner M.

Rofo. 2012 Feb;184(2):105-12. doi: 10.1055/s-0031-1281982. Epub 2011 Dec 16.

PMID:
22179768
10.

Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.

Lüdemann L, Nafz B, Elsner F, Grosse-Siestrup C, Meissler M, Kaufels N, Rehbein H, Persson PB, Michaely HJ, Lengsfeld P, Voth M, Gutberlet M.

Invest Radiol. 2009 Mar;44(3):125-34. doi: 10.1097/RLI.0b013e318193598c.

PMID:
19151609
11.

Partition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumine.

Kawel N, Nacif M, Santini F, Liu S, Bremerich J, Arai AE, Bluemke DA.

J Magn Reson Imaging. 2012 Sep;36(3):733-7. doi: 10.1002/jmri.23651. Epub 2012 Apr 5.

12.

T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 May 1;14:27. doi: 10.1186/1532-429X-14-27.

13.

Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model--comparison of gadofosveset and gadopentetate dimeglumine.

Lobbes MB, Miserus RJ, Heeneman S, Passos VL, Mutsaers PH, Debernardi N, Misselwitz B, Post M, Daemen MJ, van Engelshoven JM, Leiner T, Kooi ME.

Radiology. 2009 Mar;250(3):682-91. doi: 10.1148/radiol.2503080875.

PMID:
19244042
14.

Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.

Hadizadeh DR, Jost G, Pietsch H, Weibrecht M, Perkuhn M, Boschewitz JM, Keil VC, Träber F, Kukuk GM, Schild HH, Willinek WA.

Invest Radiol. 2014 Jul;49(7):457-64. doi: 10.1097/RLI.0000000000000036.

PMID:
24598442
15.

Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.

Bauner KU, Reiser MF, Huber AM.

Invest Radiol. 2009 Feb;44(2):95-104. doi: 10.1097/RLI.0b013e3181911eab.

PMID:
19077911
16.

Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.

Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.

Acad Radiol. 2006 Jun;13(6):744-51.

PMID:
16679277
17.

Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.

Fan B, Li M, Wang X, Xu Y, Li F, Zhang L, Jiang J, Jiang Y.

J Magn Reson Imaging. 2017 Jun;45(6):1827-1834. doi: 10.1002/jmri.25491. Epub 2016 Oct 3.

PMID:
27696616
18.
19.

Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.

Durmus T, Schilling R, Doeblin P, Huppertz A, Hamm B, Taupitz M, Wagner M.

Invest Radiol. 2012 Mar;47(3):183-8. doi: 10.1097/RLI.0b013e318236e354.

PMID:
22183078
20.

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.

Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.

Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.

PMID:
20351653

Supplemental Content

Support Center